Cargando…

Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria

BACKGROUND: Although previous studies showed an increasing prevalence of infections due to multi-drug resistant (MDR) bacteria in the community, specific data on sepsis are lacking. We aimed to assess prevalence, risk factors and outcomes of patients with sepsis due to MDR bacteria. METHODS: An obse...

Descripción completa

Detalles Bibliográficos
Autores principales: Capsoni, Nicolò, Bellone, Pietro, Aliberti, Stefano, Sotgiu, Giovanni, Pavanello, Donatella, Visintin, Benedetto, Callisto, Elena, Saderi, Laura, Soldini, Davide, Lardera, Luca, Monzani, Valter, Brambilla, Anna Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610920/
https://www.ncbi.nlm.nih.gov/pubmed/31312449
http://dx.doi.org/10.1186/s40248-019-0185-4
_version_ 1783432590693236736
author Capsoni, Nicolò
Bellone, Pietro
Aliberti, Stefano
Sotgiu, Giovanni
Pavanello, Donatella
Visintin, Benedetto
Callisto, Elena
Saderi, Laura
Soldini, Davide
Lardera, Luca
Monzani, Valter
Brambilla, Anna Maria
author_facet Capsoni, Nicolò
Bellone, Pietro
Aliberti, Stefano
Sotgiu, Giovanni
Pavanello, Donatella
Visintin, Benedetto
Callisto, Elena
Saderi, Laura
Soldini, Davide
Lardera, Luca
Monzani, Valter
Brambilla, Anna Maria
author_sort Capsoni, Nicolò
collection PubMed
description BACKGROUND: Although previous studies showed an increasing prevalence of infections due to multi-drug resistant (MDR) bacteria in the community, specific data on sepsis are lacking. We aimed to assess prevalence, risk factors and outcomes of patients with sepsis due to MDR bacteria. METHODS: An observational, retrospective study was conducted on consecutive adult patients coming from the community and admitted to the Policlinico Hospital, Milan, Italy, with a diagnosis of sepsis between January 2011 and December 2015. Primary study outcome was in-hospital mortality. RESULTS: Among 518 patients, at least one MDR bacteria was isolated in 88 (17%). ESBL+ Enterobacteriaceae were the most prevalent MDR bacteria (9.7%) followed by MRSA (3.9%). Independent risk factors for sepsis due to MDR bacteria were septic shock (OR: 2.2; p = 0.002) and hospitalization in the previous 90 days (OR: 2.3; p = 0.003). Independent risk factors for sepsis due to ESBL+ bacteria were hospitalization in the previous 90 days (OR: 2.1; p = 0.02) and stroke (OR: 2.1; p = 0.04). A significantly higher mortality was detected among patients with vs. without MDR bacteria (40.2% vs. 23.1% respectively, p = 0.001). Independent risk factors for mortality among patients with sepsis were coagulation dysfunction (OR: 3.2; p = 0.03), septic shock (OR: 3.2; p = 0.003), and isolation of a MDR bacteria (OR: 4.6; p < 0.001). CONCLUSION: In light of the prevalence and impact of MDR bacteria causing sepsis in patients coming from the community, physicians should consider ESBL coverage when starting an empiric antibiotic therapy in patients with specific risk factors, especially in the presence of septic shock. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40248-019-0185-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6610920
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66109202019-07-16 Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria Capsoni, Nicolò Bellone, Pietro Aliberti, Stefano Sotgiu, Giovanni Pavanello, Donatella Visintin, Benedetto Callisto, Elena Saderi, Laura Soldini, Davide Lardera, Luca Monzani, Valter Brambilla, Anna Maria Multidiscip Respir Med Original Research Article BACKGROUND: Although previous studies showed an increasing prevalence of infections due to multi-drug resistant (MDR) bacteria in the community, specific data on sepsis are lacking. We aimed to assess prevalence, risk factors and outcomes of patients with sepsis due to MDR bacteria. METHODS: An observational, retrospective study was conducted on consecutive adult patients coming from the community and admitted to the Policlinico Hospital, Milan, Italy, with a diagnosis of sepsis between January 2011 and December 2015. Primary study outcome was in-hospital mortality. RESULTS: Among 518 patients, at least one MDR bacteria was isolated in 88 (17%). ESBL+ Enterobacteriaceae were the most prevalent MDR bacteria (9.7%) followed by MRSA (3.9%). Independent risk factors for sepsis due to MDR bacteria were septic shock (OR: 2.2; p = 0.002) and hospitalization in the previous 90 days (OR: 2.3; p = 0.003). Independent risk factors for sepsis due to ESBL+ bacteria were hospitalization in the previous 90 days (OR: 2.1; p = 0.02) and stroke (OR: 2.1; p = 0.04). A significantly higher mortality was detected among patients with vs. without MDR bacteria (40.2% vs. 23.1% respectively, p = 0.001). Independent risk factors for mortality among patients with sepsis were coagulation dysfunction (OR: 3.2; p = 0.03), septic shock (OR: 3.2; p = 0.003), and isolation of a MDR bacteria (OR: 4.6; p < 0.001). CONCLUSION: In light of the prevalence and impact of MDR bacteria causing sepsis in patients coming from the community, physicians should consider ESBL coverage when starting an empiric antibiotic therapy in patients with specific risk factors, especially in the presence of septic shock. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40248-019-0185-4) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-05 /pmc/articles/PMC6610920/ /pubmed/31312449 http://dx.doi.org/10.1186/s40248-019-0185-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Research Article
Capsoni, Nicolò
Bellone, Pietro
Aliberti, Stefano
Sotgiu, Giovanni
Pavanello, Donatella
Visintin, Benedetto
Callisto, Elena
Saderi, Laura
Soldini, Davide
Lardera, Luca
Monzani, Valter
Brambilla, Anna Maria
Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria
title Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria
title_full Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria
title_fullStr Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria
title_full_unstemmed Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria
title_short Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria
title_sort prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610920/
https://www.ncbi.nlm.nih.gov/pubmed/31312449
http://dx.doi.org/10.1186/s40248-019-0185-4
work_keys_str_mv AT capsoninicolo prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria
AT bellonepietro prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria
AT alibertistefano prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria
AT sotgiugiovanni prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria
AT pavanellodonatella prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria
AT visintinbenedetto prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria
AT callistoelena prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria
AT saderilaura prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria
AT soldinidavide prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria
AT larderaluca prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria
AT monzanivalter prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria
AT brambillaannamaria prevalenceriskfactorsandoutcomesofpatientscomingfromthecommunitywithsepsisduetomultidrugresistantbacteria